<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/'><id>tag:blogger.com,1999:blog-28450497.post7064888958453925507..comments</id><updated>2009-12-01T16:15:33.265-05:00</updated><category term='Channel Management'/><category term='Supply Chain Technology'/><category term='Blog Administration'/><category term='Importation'/><category term='Health Care Policy'/><category term='Group Purchasing Organizations (GPOs)'/><category term='Drug Shortages'/><category term='Industry Trends'/><category term='Fun Stuff'/><category term='PBMs'/><category term='Wholesalers'/><category term='Pharmacy Economics'/><category term='Pharmacy'/><category term='Supply Chain Humor'/><category term='Drug Counterfeiting'/><category term='Health Care Reform'/><category term='Pharmacogenomics'/><category term='Pedigree'/><category term='Specialty Drugs'/><category term='Medicare Part D'/><category term='Average Sales Price (ASP)'/><category term='Accountable Care Organizations (ACOs)'/><category term='Generic Drugs'/><category term='Guest Post'/><category term='Marketing'/><category term='RFID'/><category term='Average Acquisition Cost (AAC)'/><category term='International Drug Channels'/><category term='Enforcement'/><category term='Costs/Reimbursement'/><category term='Average Manufacturer Price (AMP)'/><category term='Mergers and Acquisitions'/><title type='text'>Comments on Drug Channels: A New Opportunity to Reach the Drug Channels Audie...</title><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://www.drugchannels.net/feeds/7064888958453925507/comments/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html'/><author><name>Adam J. Fein, Ph.D.</name><uri>http://www.blogger.com/profile/12217252282643255442</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='25' height='32' src='http://4.bp.blogspot.com/_jauTfEtde80/TTnq9WCPzYI/AAAAAAAAAAM/VNKwcn8y_BA/s220/AdamJFein-DrugChannels.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>6</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-28450497.post-8666518288400054944</id><published>2009-12-01T13:34:38.398-05:00</published><updated>2009-12-01T13:34:38.398-05:00</updated><title type='text'>Hmmm! ..and all along I thought you were fully spo...</title><content type='html'>Hmmm! ..and all along I thought you were fully sponsored by PhRMA and PCMA.</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/8666518288400054944'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/8666518288400054944'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html?showComment=1259692478398#c8666518288400054944' title=''/><author><name>Richard Beck</name><uri>http://txrxcouncil.org</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html' ref='tag:blogger.com,1999:blog-28450497.post-7064888958453925507' source='http://www.blogger.com/feeds/28450497/posts/default/7064888958453925507' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-574706692'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-6694758206459948303</id><published>2009-11-20T10:22:53.196-05:00</published><updated>2009-11-20T10:22:53.196-05:00</updated><title type='text'>Adam,

Really, Haliburton too?

And truly, I belie...</title><content type='html'>Adam,&lt;br /&gt;&lt;br /&gt;Really, Haliburton too?&lt;br /&gt;&lt;br /&gt;And truly, I believe the last thing we need is more clutter. We&amp;#39;re looking to get new information in a quick and easy to read format....such as yours. (And your style is great).&lt;br /&gt;&lt;br /&gt;It actually would be quite interesting to see what OTHER blogs/sites your readers are checking out as well.&lt;br /&gt;&lt;br /&gt;Thanks Adam.</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/6694758206459948303'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/6694758206459948303'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html?showComment=1258730573196#c6694758206459948303' title=''/><author><name>Anonymous</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html' ref='tag:blogger.com,1999:blog-28450497.post-7064888958453925507' source='http://www.blogger.com/feeds/28450497/posts/default/7064888958453925507' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-2066242219'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-4760053651889217875</id><published>2009-11-20T10:06:54.171-05:00</published><updated>2009-11-20T10:06:54.171-05:00</updated><title type='text'>Congratulations on your progress!  Your timing is ...</title><content type='html'>Congratulations on your progress!  Your timing is perfect to celebrate with a glass of long awaited Knob Creek!</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/4760053651889217875'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/4760053651889217875'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html?showComment=1258729614171#c4760053651889217875' title=''/><author><name>Anonymous</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html' ref='tag:blogger.com,1999:blog-28450497.post-7064888958453925507' source='http://www.blogger.com/feeds/28450497/posts/default/7064888958453925507' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-526565941'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-4459757232453013346</id><published>2009-11-20T10:04:23.056-05:00</published><updated>2009-11-20T10:04:23.056-05:00</updated><title type='text'>Dirk,

If I start extolling the virtues of online ...</title><content type='html'>Dirk,&lt;br /&gt;&lt;br /&gt;If I start extolling the virtues of online pharmacies based in the mountains of Kabul, then you&amp;#39;ll know that I&amp;#39;ve gone too far.&lt;br /&gt;&lt;br /&gt;Adam</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/4459757232453013346'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/4459757232453013346'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html?showComment=1258729463056#c4459757232453013346' title=''/><author><name>Adam J. Fein, Ph.D.</name><uri>http://www.blogger.com/profile/15774296048321605590</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='21' height='32' src='http://4.bp.blogspot.com/_dWcjP1QZBJI/SNqpTSyKLsI/AAAAAAAAAXs/Gi885_wIDXs/S220/Adam~J~Fein~photo.jpg'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html' ref='tag:blogger.com,1999:blog-28450497.post-7064888958453925507' source='http://www.blogger.com/feeds/28450497/posts/default/7064888958453925507' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-1955505852'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-4533118336550611982</id><published>2009-11-20T09:59:42.277-05:00</published><updated>2009-11-20T09:59:42.277-05:00</updated><title type='text'>Adam,
I can understand the huge value to potential...</title><content type='html'>Adam,&lt;br /&gt;I can understand the huge value to potential sponsors for your offer, and I think your plan is very reasonable and would be unobtrusive to readers, but did you have to offer the ability to request a specific blog topic?  I think the right sponsors should just be happy to have their names on the same page as your content without needing to control your focus, even once, and even though you would retain editorial control.</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/4533118336550611982'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/4533118336550611982'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html?showComment=1258729182277#c4533118336550611982' title=''/><author><name>Dirk Rodgers</name><uri>http://www.blogger.com/profile/09020940758489540982</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='24' height='32' src='http://3.bp.blogspot.com/_RT_bgliFJLI/SlVApUVOb6I/AAAAAAAAAAM/aihT9XDBPBg/S220/DSCF1293_crop.2.JPG'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html' ref='tag:blogger.com,1999:blog-28450497.post-7064888958453925507' source='http://www.blogger.com/feeds/28450497/posts/default/7064888958453925507' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-1516043457'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-8092873366097934297</id><published>2009-11-20T09:47:45.198-05:00</published><updated>2009-11-20T09:47:45.198-05:00</updated><title type='text'>Adam, I assure you there are more companies, way m...</title><content type='html'>Adam, I assure you there are more companies, way more, than those listed.  I know of many execs that read your postings from home networks, especially those that have &amp;quot;blocks&amp;quot; at work on internet use.  This also does not include the people that read from home offices.  Can&amp;#39;t wait to see who signs up!</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/8092873366097934297'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/7064888958453925507/comments/default/8092873366097934297'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html?showComment=1258728465198#c8092873366097934297' title=''/><author><name>Al Godley</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2009/11/new-opportunity-to-reach-drug-channels.html' ref='tag:blogger.com,1999:blog-28450497.post-7064888958453925507' source='http://www.blogger.com/feeds/28450497/posts/default/7064888958453925507' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-2099968433'/></entry></feed>
